Literature DB >> 24349990

Video-atlas on minimally invasive mitral valve surgery-The David Adams technique.

Javier G Castillo1, Federico Milla1, Anelechi C Anyanwu1, David H Adams1.   

Abstract

Median sternotomy has unquestionably evolved over recent decades. Modern sternotomy involves a 7-8 cm lower midline skin incision, tunneling of the subcutaneous tissues with subsequent creation of myocutaneous flaps, full sternotomy, and standard cardiopulmonary bypass techniques with central cannulation. In experienced centers, modern sternotomy may achieve all the goals of minimally invasive surgery, including excellent cosmesis, excellent postoperative pain control, low rates of bleeding and transfusion (our re-exploration rate for bleeding is <1%), and the ability to perform any reconstructive technique that would be used in a standard sternotomy, with very high repair rates (our most recent series documented a repair rate exceeding 99% in an all-comers population of degenerative disease regardless of complexity).

Entities:  

Keywords:  Modern sternotomy; complex mitral valve repair

Year:  2013        PMID: 24349990      PMCID: PMC3857000          DOI: 10.3978/j.issn.2225-319X.2013.10.10

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  9 in total

1.  Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse.

Authors:  Joerg Seeburger; Michael A Borger; Nicolas Doll; Thomas Walther; Jurgen Passage; Volkmar Falk; Friedrich W Mohr
Journal:  Eur J Cardiothorac Surg       Date:  2009-05-22       Impact factor: 4.191

2.  Minimally invasive valve operations.

Authors:  D M Cosgrove; J F Sabik; J L Navia
Journal:  Ann Thorac Surg       Date:  1998-06       Impact factor: 4.330

3.  Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: establishing the benchmark against which percutaneous interventions should be judged.

Authors:  Rakesh M Suri; Harold M Burkhart; Richard C Daly; Joseph A Dearani; Soon J Park; Thoralf M Sundt; Zhuo Li; Maurice Enriquez-Sarano; Hartzell V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-10       Impact factor: 5.209

4.  A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines.

Authors:  Javier G Castillo; Anelechi C Anyanwu; Valentin Fuster; David H Adams
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-12       Impact factor: 5.209

5.  Mitral valve surgery can now routinely be performed endoscopically.

Authors:  Filip P Casselman; Sam Van Slycke; Francis Wellens; Raphael De Geest; Ivan Degrieck; Frank Van Praet; Yvette Vermeulen; Hugo Vanermen
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

6.  Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease.

Authors:  Tirone E David; Susan Armstrong; Brian W McCrindle; Cedric Manlhiot
Journal:  Circulation       Date:  2013-03-04       Impact factor: 29.690

7.  Robotic mitral valve repairs in 300 patients: a single-center experience.

Authors:  W Randolph Chitwood; Evelio Rodriguez; Michael W A Chu; Ansar Hassan; T Bruce Ferguson; Paul W Vos; L Wiley Nifong
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08       Impact factor: 5.209

8.  One thousand minimally invasive mitral valve operations: early outcomes, late outcomes, and echocardiographic follow-up.

Authors:  R Scott McClure; Leonidas V Athanasopoulos; Siobhan McGurk; Michael J Davidson; Gregory S Couper; Lawrence H Cohn
Journal:  J Thorac Cardiovasc Surg       Date:  2013-01-23       Impact factor: 5.209

9.  Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets.

Authors:  Rakesh M Suri; Jean-Louis Vanoverschelde; Francesco Grigioni; Hartzell V Schaff; Christophe Tribouilloy; Jean-Francois Avierinos; Andrea Barbieri; Agnes Pasquet; Marianne Huebner; Dan Rusinaru; Antonio Russo; Hector I Michelena; Maurice Enriquez-Sarano
Journal:  JAMA       Date:  2013-08-14       Impact factor: 56.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.